Skip to main content
. 2020 Apr 24;13(9):1342–1346. doi: 10.1016/j.jiph.2020.04.007

Table 3.

Medications were used during hospitalization of 51 positive MERS-CoV cases in Najran.

Medication N %
Ceftriaxone 14 27.5%
Oseltamivir 34 66.7%
Piperacillin / Tazobactam (Tazocin) 19 37.3%
Meropenem 9 17.6%
Vancomycin 14 27.5%
Azithromycin 34 66.7%
Moxifloxacin 5 9.8%
Linezolid 5 9.8%